ArticleOpen life sciences2022

Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial-mesenchymal transition.

Chuntao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.